Liquid chromatography–negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human plasma

Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia

Carlos A. Dujovne, Mark P. Ettinger, J. Frederick McNeer et al. · The American Journal of Cardiology · 2002 · 385 citations

Primary Hypercholesterolemia, Lipid Disorder, Cardiovascular Disease +6

Discovery of 1-(4-Fluorophenyl)-(3<i>R</i>)-[3-(4-fluorophenyl)-(3<i>S</i>)- hydroxypropyl]-(4<i>S</i>)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235):  A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption

Stuart B. Rosenblum, Tram Huynh, Adriano Afonso et al. · Journal of Medicinal Chemistry · 1998 · 352 citations

Serum Total Cholesterol, Pharmaceutical Science, Pharmacotherapy +18

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

Margaret van Heek, Constance Farley, Douglas S. Compton et al. · British Journal of Pharmacology · 2000 · 327 citations · Full text

Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies

Harold Bays, Paul B. Moore, Margaret Drehobl et al. · Clinical Therapeutics · 2001 · 311 citations

Primary Hypercholesterolemia, Cardiovascular Disease, Hyperlipidemia +5

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

Boris Kerzner, John Corbelli, Stephan C. Sharp et al. · The American Journal of Cardiology · 2003 · 217 citations

Thrombosis, Primary Hypercholesterolemia, Lipid Disorder +9